Skip to main content

Bausch Health vs United Airlines: Founders, CEOs and History

Bausch Health was founded in 1994 by Eugene Melnyk, Milan Panic and is led by Thomas J. Appio. United Airlines was founded in 1926 by Walter T. Varney, William Boeing and is led by Scott Kirby.

Company facts

Bausch Health

Founded
1994
Headquarters
Laval, Quebec, Canada
Current CEO
Thomas J. Appio
Employees
20,300

United Airlines

Founded
1926
Headquarters
Chicago, Illinois
Current CEO
Scott Kirby
Employees
113,200

Founders

Bausch Health

  • Eugene Melnyk

    Eugene Melnyk built Biovail into Canada's largest publicly traded pharmaceutical company, with revenue growing from about $19M in 1995 to roughly $1.07B in 2006.

  • Milan Panic

    Milan Panic ran ICN Pharmaceuticals for four decades and made it known for the broad-spectrum antiviral ribavirin, sold as Virazole.

Bausch Health founders in full

United Airlines

  • Walter T. Varney

    Walter T. Varney founded Varney Air Lines, which won Contract Air Mail Route 5 and flew its first route between Pasco, Washington, and Elko, Nevada, via Boise, on April 6, 1926.

  • William Boeing

    William Boeing formed Boeing Air Transport in 1927 to fly the Chicago-San Francisco air mail route and then, with Frederick Rentschler, created United Aircraft and Transport Corporation in 1929.

United Airlines founders in full

CEOs and their tenures

Bausch Health

  1. J. Michael Pearson2008–2016

    Former Chief Executive Officer

    Pearson, a former McKinsey director, became chief executive of Valeant Pharmaceuticals effective February 1, 2008 and ran the company through the September 2010 merger with Canada's Biovail until early May 2016.

    Source
  2. Joseph C. Papa2016–2022

    Former Chief Executive Officer

    Papa, previously chief executive of Perrigo, was named chairman and CEO in April 2016 and took over in early May 2016, inheriting about $30B of debt, an SEC investigation and congressional scrutiny of Valeant-era drug pricing.

    Source
  3. Thomas J. Appio2022–present

    Chief Executive Officer

    Appio became chief executive officer and a director in May 2022, succeeding Joseph Papa.

    Source
Bausch Health CEO history in full

United Airlines

  1. Oscar Munoz2015–2020

    Former CEO

    Munoz handed over to Scott Kirby in May 2020 and served as executive chairman for a transition period.

    Source
  2. J. Scott Kirby2020–present

    Chief Executive Officer

    Under Kirby, United's revenue rose from $15.4 billion in 2020 to a record $59.1 billion in 2025, with premium cabins and MileagePlus as the main growth drivers.

    Source
United Airlines CEO history in full

Timeline: Bausch Health and United Airlines side by side

  1. 1926United Airlines

    Varney Air Lines begins

    United traces its roots to Varney Air Lines and early air mail service.

  2. 1931United Airlines

    United Air Lines organized

    United Air Lines was formed to manage airline subsidiaries tied to United Aircraft and Transport.

  3. 1959Bausch Health

    Milan Panic founds ICN Pharmaceuticals

    Milan Panic, a Yugoslav immigrant to California, founded ICN Pharmaceuticals in 1959 and ran it for four decades. ICN is the predecessor of Valeant Pharmaceuticals and of today's Bausch Health.

  4. 1994Bausch Health

    Biovail Corporation International formed in Canada

    On March 29, 1994 Eugene Melnyk consolidated his Canadian drug-delivery business by amalgamating Trimel Corporation with its subsidiary to create Biovail Corporation International, the legal entity that files today as Bausch Health Companies Inc.

  5. 1997United Airlines

    Star Alliance founded

    United became one of the founding members of Star Alliance.

  6. 2003Bausch Health

    ICN renames itself Valeant Pharmaceuticals

    ICN Pharmaceuticals, then based in Costa Mesa, California, took the Valeant Pharmaceuticals name in November 2003 to distance itself from the governance fights of the Panic era.

  7. 2008Bausch Health

    J. Michael Pearson becomes chief executive

    Valeant appointed former McKinsey director J. Michael Pearson as chief executive effective February 1, 2008, succeeding Timothy C. Tyson. Pearson replaced internal research spending with debt-funded acquisitions of marketed drugs.

  8. 2010Bausch Health

    Biovail and Valeant complete their merger

    The merger of Biovail Corporation and Valeant Pharmaceuticals International closed on September 28, 2010. The combined company kept the Valeant name and Pearson as chief executive but was incorporated in Canada.

  9. 2010United Airlines

    Continental merger closes

    UAL Corporation completed the Continental merger, later operating under the United brand.

  10. 2011Bausch Health

    Ortho Dermatologics bought from Johnson and Johnson

    Valeant agreed to acquire the U.S. Ortho Dermatologics assets from Janssen Pharmaceuticals, a Johnson and Johnson company, for about $345M in cash, building the dermatology franchise.

  11. 2013Bausch Health

    Bausch + Lomb acquired for $8.7 billion

    Valeant agreed in May 2013 to buy eye-health company Bausch + Lomb from Warburg Pincus for $8.7B in cash, adding contact lenses, lens care, ophthalmic drugs and surgical devices.

  12. 2015Bausch Health

    Salix acquisition closes at about $11.1 billion

    Valeant completed its tender offer for Salix Pharmaceuticals on April 1, 2015 at $173 per share, about $11.1B in equity value and roughly $15.8B including debt, gaining the Xifaxan franchise.

  13. 2015Bausch Health

    Drug pricing and Philidor scandal breaks

    Congressional investigators pressed Valeant over 525% and 212% increases on the heart drugs Isuprel and Nitropress, bought in February 2015, and over its undisclosed ties to the Philidor mail-order pharmacy.

  14. 2015United Airlines

    Oscar Munoz becomes CEO

    Oscar Munoz became chief executive of United in September 2015.

  15. 2016Bausch Health

    Joseph Papa replaces Pearson as chief executive

    Valeant named Perrigo chief executive Joseph C. Papa as chairman and CEO on April 25, 2016, and he took over in early May 2016 with about $30B of debt outstanding.

  16. 2017Bausch Health

    Skincare brands and Dendreon sold to cut debt

    Valeant sold the CeraVe, AcneFree and AMBI skincare brands to L'Oreal for about $1.3B and the Dendreon cancer unit to China's Sanpower Group for about $820M, using the proceeds to repay debt.

  17. 2018Bausch Health

    Company renamed Bausch Health Companies Inc.

    The name change from Valeant Pharmaceuticals International, Inc. to Bausch Health Companies Inc. was completed on July 13, 2018, and the shares began trading as BHC on the NYSE and TSX on July 16, 2018.

  18. 2020Bausch Health

    SEC settlement closes the Philidor accounting case

    On July 31, 2020 Bausch Health agreed to pay a $45M civil penalty to settle SEC charges of improper revenue recognition and misleading disclosures tied to Philidor. Former chief executive J. Michael Pearson and two other executives also settled.

  19. 2020United Airlines

    Scott Kirby becomes CEO

    Scott Kirby succeeded Oscar Munoz as CEO in May 2020.

  20. 2022Bausch Health

    Bausch + Lomb listed on the NYSE and TSX

    Bausch + Lomb common stock began trading under the ticker BLCO on May 6, 2022, and a Bausch Health subsidiary sold 35,000,000 Bausch + Lomb shares in the offering. Bausch Health retained about 88% of the eye-health company and still consolidates it. Thomas J.

  21. 2025Bausch Health

    DURECT acquired and record annual revenue reported

    Bausch Health closed the DURECT acquisition on September 11, 2025 for about $63M upfront, completed Solta Medical's Chinese aesthetics distribution purchase on December 1, 2025, and reported FY2025 revenue of $10.266B, up 7%, with net income attributable to Ba…

  22. 2025United Airlines

    Revenue reaches record level

    United reported record 2025 total operating revenue of $59.1 billion.

  23. 2026Bausch Health

    RED-C trials miss endpoints and trigger a $1.4 billion charge

    In January 2026 the two Phase 3 RED-C trials of amorphous-rifaximin soluble solid dispersion for primary prevention of hepatic encephalopathy missed their primary endpoints.

  24. 2026Bausch Health

    Second-quarter 2026 revenue of $2.85 billion and raised guidance

    Bausch Health reported second-quarter 2026 revenue of $2.85B, up 13%, net income attributable to Bausch Health of $258M and adjusted EBITDA of $1.075B, and raised its full-year 2026 revenue, adjusted EBITDA and cash flow guidance.

  25. 2026United Airlines

    Q2 2026 revenue up 16%

    United reported Q2 2026 revenue of $17.7 billion and raised full-year adjusted EPS guidance to $9-$11 despite nearly $6 billion in added fuel costs.

Acquisitions

Bausch Health

  • DURECT Corporation2025$63M
  • Shibo Zhenmei aesthetics distribution business2025Undisclosed
  • Salix Pharmaceuticals2015$11.1B
  • Bausch + Lomb Holdings2013$8.7B
  • Ortho Dermatologics2011$345M
All Bausch Health acquisitions

United Airlines

  • Continental Airlines2010Undisclosed
All United Airlines acquisitions

Questions about Bausch Health vs United Airlines

Who is the CEO of Bausch Health Companies Inc. and United Airlines Holdings, Inc.?

Bausch Health Companies Inc. is led by Thomas J. Appio and United Airlines Holdings, Inc. is led by Scott Kirby. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was Bausch Health Companies Inc. founded vs United Airlines Holdings, Inc.?

United Airlines Holdings, Inc. was founded in 1926 — 68 years before Bausch Health Companies Inc., which was founded in 1994. United Airlines Holdings, Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Bausch Health Companies Inc..

How many employees does Bausch Health Companies Inc. have compared to United Airlines Holdings, Inc.?

Bausch Health Companies Inc. employs approximately 20,300 people, while United Airlines Holdings, Inc. employs approximately 113,200. United Airlines Holdings, Inc. has the larger workforce at 113,200 employees, compared to Bausch Health Companies Inc.'s 20,300. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are Bausch Health Companies Inc. and United Airlines Holdings, Inc. headquartered?

Bausch Health Companies Inc. is headquartered in Canada and United Airlines Holdings, Inc. is headquartered in United States. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded Bausch Health Companies Inc. and United Airlines Holdings, Inc.?

Bausch Health Companies Inc. was founded by Eugene Melnyk, Milan Panic. United Airlines Holdings, Inc. was founded by Walter T. Varney, William Boeing.

Which company has a longer operating history — Bausch Health Companies Inc. or United Airlines Holdings, Inc.?

United Airlines Holdings, Inc. has been operating for approximately 100 years, making it the more established of the two companies. Bausch Health Companies Inc. has been in operation for around 32 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Bausch Health vs United Airlines overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.